For most of us working in healthcare communications, the best buzz is when the work has clearly reached those who are most in need of support.
Marco has recently funded a $10 million Asset-Based Lending (ABL) revolving facility for a pharmaceutical wholesaler. PRESS RELEASE FROM MARCO.
A predictable regulatory environment that rewards pharmaceutical companies for developing innovative, high-value treatments is essential, said the Czech, ...
The Polish initiative establishes a proactive strategy for securing access to essential medicines and maintaining pharmaceutical supplies in times of ...
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and.
Tokyo, Japan and Cambridge, UK, 20 December 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei...
The three pharmaceutical companies listed on the Jamaica Stock Exchange are enduring pain. Two posted losses in their latest quarter, and the third missed ...
The needle-free drug injection system market is expected to reach USD 606 million in the current year and is anticipated to grow at a CAGR of 4% to 2035.
The UK's DHSC has announced its anticipated 2025 headline payback rate for new medicines under the 2024–2028 VPAG.
When it comes to media strategy, the line between “spending” and “investing” can be as hazy as a misty morning. The difference? Spending is throwing money ...
Sorriso Pharmaceuticals announced that it is looking to move to Phase II after its ulcerative colitis treatment saw success over placebo.
Anna-Maria Hoffmann-Vold, MD, PhD, discusses progressive pulmonary fibrosis, its primary causes and the key risk factors contributing to its development and ...
The CEO of Danish drugmaker Zealand Pharma said on Friday that data posted by Novo Nordisk's late-stage study of its next-generation obesity drug CagriSema ...
Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea.